Role of Opioid Antagonists in the Treatment of Women with Glucoregulation Abnormalities

E-ISSN： 1873-4286|12|8|1001-1012

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.8, 2006-03, pp. : 1001-1012

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological options for maintenance treatment of opioid dependence include opioid agonists and antagonists

Drugs & Therapy Perspectives, Vol. 28, Iss. 8, 2012-08 ,pp. : 11-14

Adis International

Access to resources Recommend Favorite

The role of mineralocorticoid receptor antagonists in the treatment of cardiac failure

By Funder John W

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 12, 2003-12 ,pp. : 1963-1969

Informa Healthcare

Access to resources Recommend Favorite

Novel opioid antagonists for opioid-induced bowel dysfunction

By Diego Laura Atayee Rabia Helmons Pieter Hsiao Grace von Gunten Charles F

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1047-1056

Informa Healthcare

Access to resources Recommend Favorite

Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats

By Gallate Jason Mallet Paul McGregor Iain

Psychopharmacology, Vol. 173, Iss. 1-2, 2004-04 ,pp. : 210-216

Springer Publishing Company

Access to resources Recommend Favorite

Ultraselective antagonists of the d-opioid receptor

By Lazarus L.H. Salvadori S. Temussi P.A. Balboni G. Guerrini R. Bryant S.D. Cooper P.S.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 45-47

Informa Healthcare

Access to resources Recommend Favorite